Alcoholic liver disease: Clinical and sonographic features

Journal of Medical Ultrasound

Volumn 16, Issue 2, 2008, Pages 140-149

  Yang, Sien Sing ^a  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Alcoholic liver disease; Diagnosis; Sonography

Indexed keywords

ALCOHOL;

ALCOHOL LIVER DISEASE; ALCOHOLIC FATTY LIVER; ALCOHOLISM; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE EXACERBATION; ECHOGRAPHY; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER INJURY; PUBLIC HEALTH; REVIEW; VIRUS REPLICATION;

EID: 48049116187     PISSN: 09296441     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6441(08)60015-6     Document Type: Article

References (106)

1. Sung JL, Chen DS, Lai MY, et al. Epidemiological study on hepatitis B virus infection in Taiwan. Chin J Gastroenterol 1984;1:1-9.
2. Chen DS, Kuo GC, Sung JL, et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 1990;162:817-22.
3. Lin CW, Hu RT, Yang SS, et al. Changing severe alcoholic liver disease in Taiwan. Taiwan J Gastroenterol 2004;21:92.
4. Lin CW, Hu JT, Lin GL, et al. Discriminant function > 16 combination with varices predicts mortality in patients with alcoholic liver disease. Taiwan J Gastroenterol 2008;25:65.
5. Balasubramanian S, Kowdley KV. Effect of alcohol on viral hepatitis and other forms of liver dysfunction. Clin Liver Dis 2005;9:83-101.
6. Schiff ER. The alcoholic patient with hepatitis C virus infection. Am J Med 1999;107(6 Suppl 2):95S-9S.
7. Wong LL, Limm WM, Tsai NK, et al. Hepatitis B and alcohol affect survival of hepatocellular carcinoma patients. World J Gastroenterol 2005;11:3491-7.
8. Stickel F, Hoehn B, Schuppan D, et al. Nutritional therapy in alcoholic liver disease. Aliment Pharmacol Ther 2003;18:357-73.
9. Mezey F. Interaction between alcohol and nutrition in the pathogenesis of alcoholic liver disease. Semin Liver Dis 1991;11:340-8.
10. Becker U, Deis A, Sorensen TI, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996;23: 1025-9.
11. Greenfield TK, Rehm J, Rogers J. Effects of depression and social integration on the relationship between alcohol consumption and all-cause mortality. Addiction 2002;97:29-38.
12. Bertoletti A, Ferrari C. Kinetics of the immune response during HBV and HCV infection. Hepatology 2003;38:4-13.
13. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
14. Lieber CS. Metabolism of alcohol. Clin Liver Dis 2005;9:1-35.
15. Fernández-Checa JC. Alcohol-induced liver disease: when fat and oxidative stress meet. Ann Hepatol 2003;2:69-75.
16. Stumptner C, Fuchsbichler A, Heid H, et al. Mallory body: a disease-associated type of sequestosome. Hepatology 2002;35:1053-62.
17. Akama H, Kawai S. Tumour necrosis factor and polymorphonuclear leukocytes in alcoholic hepatitis. Alcohol Alcohol 1991;26:229-30.
18. Reeves HL, Burt AD, Wood S, et al. Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis. J Hepatol 1996;25:677-83.
19. Albanis F, Friedman SL. Hepatic fibrosis: pathogenesis and principles of therapy. Clin Liver Dis 2001;5:315-34.
20. Purohit V, Brenner DA. Mechanisms of alcohol-induced hepatic fibrosis: a summary of the Ron Thurman Symposium. Hepatology 2006;43:872-8.
21. An international group. Alcoholic liver disease: morphological manifestations. Lancet 1981;1:707-11.
22. Lieber CS. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004;34:9-19.
23. Lieber CS. Biochemical and molecular basis of alcohol-induced injury to liver and other tissues. N Engl J Med 1988;319:1639-50.
24. Levitsky J, Mailliard ME. Diagnosis and therapy of alcoholic liver disease. Semin Liver Dis 2004;24:233-47.
25. Zieve L. Jaundice, hyperlipemia and hemolytic anemia: a heretofore unrecognized syndrome associated with alcoholic fatty liver and cirrhosis. Ann Intern Med 1958;48:471-96.
26. Cohen JA, Kaplan MM. The SGOT/SGPT ratio: an indicator of alcoholic liver disease. Dig Dis Sci 1979; 24:835-8.
27. Storey EL, Mack U, Powell LW, et al. Use of chromato-focusing to detect a transferrin variant in serum of alcoholic subjects. Clin Chem 1985;31:1543-5.
28. French SW, Nash J, Shitabata P, et al. Pathology of alcoholic liver disease. VA Cooperative Study Group 119. Semin Liver Dis 1993;13:154-69.
29. Talley NJ, Roth A, Woods J, et al. Diagnostic value of liver biopsy in alcoholic liver disease. J Clin Gastroenterol 1988;10:647-50.
30. Maher JJ. Alcoholic steatosis and steatohepatitis. Semin Gastrointest Dis 2002;13:31-9.
31. Chedid A, Mendenhall CL, Tosch T, et al. Significance of megamitochondria in alcoholic liver disease. Gastroenterology 1986;90:1858-64.
32. Worner TM, Lieber CS. Perivenular fibrosis as precursor lesion of cirrhosis. JAMA 1985;254:627-30.
33. Kondili LA, Taliani G, Cerga G, et al. Correlation of alcohol consumption with liver histological features in non-cirrhotic patients. Eur J Gastroenterol Hepatol 2005;17:155-9.
34. Quinn SF, Gosink BB. Characteristic sonographic signs of hepatic fatty infiltration. AJR Am J Roentgenol 1985; 145:753-5.
35. Taylor KJW, Gorelick FS, Rosenfield AT, et al. Ultrasonography of alcoholic liver disease with histological correlation. Radiology 1981;141:157-61.
36. Sanford NL, Walsh P, Matis C, et al. Is ultrasonography useful in the assessment of diffuse parenchymal liver disease? Gastroenterology 1985;89:186-91.
37. Siegelman ES, Rosen MA. Imaging of hepatic steatosis. Semin Liver Dis 2001;21:71-80.
38. Yajima Y, Ohta K, Narui T, et al. Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast. Tohoku J Exp Med 1983;139:43-50.
39. Needleman L, Kurtz AB, Rifkin MD, et al. Sonography of diffuse benign liver disease: accuracy of pattern recognition and grading. AJR Am J Roentgenol 1986;146: 1011-5.
40. Valls C, Iannacconne R, Alba E, et al. Fat in the liver: diagnosis and characterization. Eur Radiol 2006;16: 2292-308.
41. Strauss S, Gavish E, Gottlieb P, et al. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR Am J Roentgenol 2007;189: W320-3.
42. Hamer OW, Aguirre DA, Casola G, et al. Fatty liver: imaging patterns and pitfalls. Radiographics 2006;26:1637-53.
43. Karcaaltincaba M, Akhan O. Imaging of hepatic steatosis and fatty sparing. Eur J Radiol 2007;61: 33-43.
44. Gabata T, Matsui O, Kadoya M, et al. Aberrant gastric venous drainage in a focal spared area of segment IV in fatty liver: demonstration with color Doppler sonography. Radiology 1997;203:461-3.
45. Khan AN, Sherlock DJ, Wilson G, et al. Sonographic appearance of primary liver liposarcoma. J Clin Ultrasound 2000;29:44-7.
46. Kakkos SK, Yarmenitis SD, Tsamandas AC, et al. Fatty liver in obesity: relation to Doppler perfusion index measurement of the liver. Scand J Gastroenterol 2000;35:976-80.
47. Bedogni C, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006;6:33.
48. Platt JF, Rubin JM, Ellis JH. Hepatic artery resistance changes in portal vein thrombosis. Radiology 1995;196:95-8.
49. Mihmanli I, Kantarci F, Yilmaz MH, et al. Effect of diffuse fatty infiltration of the liver on hepatic artery resistance index. J Clin Ultrasound 2005;33:95-9.
50. Magalotti D, Marchesini G, Ramilli S, et al. Splanchnic haemodynamics in non-alcoholic fatty liver disease: effect of a dietary/pharmacological treatment. A pilot study. Dig Dis 2004;36:406-11.
51. Oguzkurt L, Yildirim T, Torun D, et al. Hepatic vein Doppler waveform in patients with diffuse fatty infiltration of the liver. Eur J Radiol 2005;54:253-7.
52. Edmondson HA, Peters RL, Reynolds TB, et al. Sclerosing hyaline necrosis of the liver in the chronic alcoholic. Ann Int Med 1963;59:646-73.
53. Mendenhall CL. Alcoholic hepatitis. Clin Gastroenterol 1981;10:417-41.
54. Ceccanti M, Attili A, Balducci G, et al. Acute alcoholic hepatitis. J Clin Gastroenterol 2006;40:833-41.
55. Diehl AM, Potter J, Boitnott J, et al. Relationship between pyridoxal 5′-phosphate deficiency and aminotransferase levels in alcoholic hepatitis. Gastroenterology 1984;86:632-6.
56. Goldstein LI. Enlarged, tortuous arteries and hepatic bruit. JAMA 1968;206:2518-20.
57. Maddrey WC, Boitnott JK, Bedine MS, et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978;75:193-9.
58. Akriviadis E, Botla R, Briggs W, et al. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000;119:1637-48.
59. Maddrey WC. Alcoholic hepatitis: clinicopathologic features and therapy. Semin Liver Dis 1988;8:91-102.
60. Bautista AP. Neutrophilic infiltration in alcoholic hepatitis. Alcohol 2002;27:17-21.
61. Jaeschke H. Neutrophil-mediated tissue injury in alcoholic hepatitis. Alcohol 2002;27:23-7.
62. Itoh S, Yougel T, Kawagoe K. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol 1987;82:650-4.
63. Sorbi D, Boynton J, Lindor KD. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol 1999;94:1018-22.
64. Contos MJ, Choudhury J, Mills AS, et al. The histologic spectrum of nonalcoholic fatty liver disease. Clin Liver Dis 2004;8:481-500.
65. National Institute on Alcohol Abuse and Alcoholism. Alcohol Alert No. 19: Alcohol and the Liver. PH 329. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism, 1993.
66. Yang SS, Chu NS, Liaw YF. Somatosensory evoked potentials in hepatic encephalopathy. Gastroenterology 1985;89:625-30.
67. Yang SS, Cheng KS, Lai YC, et al. Decreasing serum alpha-fetoprotein levels in predicting poor prognosis of acute hepatic failure in patients with chronic hepatitis B. J Gastroenterol 2002;37:626-32.
68. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;342: 273-5.
69. Chu CM, Liaw YF. The incidence of fulminant hepatic failure in acute viral hepatitis in Taiwan: increased risk in patients with pre-existing HBsAg carrier state. Infection 1990;18:200-3.
70. Mergo PJ, Ros PR. Imaging of diffuse liver disease. Radiol Clin North Am 1998;36:365-75.
71. Yang SS, Wu CH, Chen TK, et al. Portal blood flow in acute hepatitis with and without ascites: a non-invasive measurement using an ultrasonic Doppler. J Gastroenterol Hepatol 1995;10:36-41.
72. Ralls PW. Color Doppler sonography of the hepatic artery and portal venous system. AJR Am J Roentgenol 1990;155:517-25.
73. Sumino Y, Kravetz D, Kanel GC, et al. Ultrasonographic diagnosis of acute alcoholic hepatitis "pseudoparallel channel sign" of intrahepatic artery dilatation. Gastroenterology 1993;105:1477-82.
74. Sacerdoti D, Merkel C, Bolognesi M, et al. Hepatic arterial resistance in cirrhosis with and without portal vein thrombosis: relationships with portal hemodynamics. Gastroenterology 1995;108:1152-8.
75. Piscaglia F, Gaiani S, Zironi G, et al. Intra- and extrahepatic arterial resistances in chronic hepatitis and liver cirrhosis. Ultrasound Med Biol 1997;23: 675-82.
76. Han SH, Rice S, Cohen SM, et al. Duplex Doppler ultrasound of the hepatic artery in patients with acute alcoholic hepatitis. J Clin Gastroenterol 2002; 34:573-7.
77. Colli A, Cocciolo M, Mumoli N, et al. Hepatic artery resistance in alcoholic liver disease. Hepatology 1998;28:1182-6.
78. Adachi M, Brenner DA. Clinical syndromes of alcoholic liver disease. Dig Dis 2005;23:255-63.
79. McCullough AJ, O'Connor JFB. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 1998;93:2022-36.
80. Zoli M, Magalotti D, Grimaldi M, et al. Physical examination of the liver: Is it still worth it? Am J Gastroenterol 1995;90:1428-32.
81. Popper H. Pathologic aspects of cirrhosis. Am J Pathol 1977;87:228-64.
82. Gluud C, Christoffersen P, Eriksen J, et al. Influence of ethanol on development of hyperplastic nodules in alcoholic men with micronodular cirrhosis. Gastroenterology 1987;93:256-60.
83. Kanel G, Korula J. Alcohol liver disease. In: Kanel G, Korula J, eds. Atlas of Liver Pathology, 2nd edition. Philadelphia: Elsevier Saunders, 2005:63-77.
84. Chu NS, Yang SS. Somatosensory and brainstem auditory evoked potentials in alcoholic liver disease with and without encephalopathy. Alcohol 1987;4:225-30.
85. Chu NS, Yang SS. Portal-systemic encephalopathy: alterations in somatosensory and brainstem auditory evoked potentials. J Neurol Sci 1988;84:41-50.
86. Yang SS, Chu NS, Wu CH. The role of somatosensory evoked potentials on hepatic encephalopathy. Biomed Eng Appl Basis Comm 1997;9:154-7.
87. Richard P, Bonniaud P, Barthélémy C, et al. Valeur de l'ultrasonographie dans le diagnostic des cirrhoses. Etude prospective de 128 patients. J Radiol 1985;66:503-6.
88. Gaiani S, Gramantieri L, Venturoli N, et al. What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. J Hepatol 1997;27:979-85.
89. Nishiura T, Watanabe H, Ito M, et al. Ultrasound evaluation of the fibrosis stage in chronic liver disease by the simultaneous use of low and high frequency probes. Br J Radiol 2005;78:189-97.
90. Aubé C, Oberti F, Korali N, et al. Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol 1999;30:472-8.
91. Bolondi L, Gandolfi L, Arienti V, et al. Ultrasonography in the diagnosis of portal hypertension: diminished response of portal vessels to respiration. Radiology 1982;142:167-72.
92. Giannini E, Botta F, Borro P, et al. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut 2003;52:1200-5.
93. Trigaux JP, Van Beers B, Michel M, et al. Alcoholic liver disease: value of the left-to-right portal vein ratio in its sonographic diagnosis. Abdom Imaging 1991;16:215-20.
94. Vilgrain V, Lebrec D, Menu Y, et al. Comparison between ultrasonographic signs and the degree of portal hypertension in patients with cirrhosis. Gastrointest Radiol 1990;15:218-22.
95. Cioni G, Tincani F, D'Alimonte P, et al. Relevance of reduced portal flow velocity, low platelet count and enlarged spleen diameter in the non-invasive diagnosis of compensated liver cirrhosis. Eur J Med 1993;2:408-10.
96. Satapathy SK, Narayan S, Varma N, et al. Hyposplenism in alcoholic cirrhosis, facts or artifacts? A comparative analysis with non-alcoholic cirrhosis and extrahepatic portal venous obstruction. J Gastroenterol Hepatol 2001;16:1038-43.
97. Ferral H, Male R, Cardiel M, et al. Cirrhosis: diagnosis by liver surface analysis with high-frequency ultrasound. Gastrointest Radiol 1992;17:74-8.
98. Giorgio A, Amoroso P, Lettieri G, et al. Cirrhosis: value of caudate to right lobe ratio in diagnosis with US. Radiology 1986;161:443-5.
99. Goyal AK, Pokharna DS, Sharma SK. Ultrasonic diagnosis of cirrhosis: reference to quantitative measurements of hepatic dimensions. Gastrointest Radiol 1990;15:32-4.
100. Shapiro RS, Stancato-Pasik A, Glajchen N, et al. Color Doppler applications in hepatic imaging. Clin Imaging 1998;22:272-9.
101. Yang SS. Duplex Doppler ultrasonography in portal hypertension. J Med Ultrasound 2007;15:107-5.
102. Baranova A, Younossi ZM. The future is around the corner: noninvasive diagnosis of progressive nonalcoholic steatohepatitis. Hepatology 2008;47: 373-5.
103. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic Hepatitis C. Gastroenterology 2005;128: 343-50.
104. Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic Hepatitis C. Hepatology 2005;41:48-54.
105. Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008;47:380-4.
106. Sagir A, Erhardt A, Schmitt M, et al. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008; 47:592-5.